Round Table Sessions

Initiated in 2015, the Round Table Discussions are a core feature of the CGC meeting. This format allows attendees to gather in a small group format to discuss current practices in clinical genomics, emerging technologies and critical concepts that affect clinical laboratory operations.

In the 2020 CGC Virtual Meeting, small breakout sessions will serve as the Round Table Discussions. As you register for the meeting, please select your desired topic. During the meeting, at the time of the discussions, participants will virtually move into different chat rooms for topic- specific gatherings. There is a limit of 12 people for each topic, so please register SOON.

2020 Round Table Session include the following topics from which participants may choose during registration:

  1. Best Practice and Clinical Utility of Genomic Testing for T-ALL

  2. Best Practice and Clinical Utility of Genomic Testing for Melanocytic lesions

  3. Influencing NCCN Recommendations for Oncology SNP Arrays in Various Cancers

  4. CGC Research Consortium: Optical Mapping Across Various Cancers

  5. Thriving as a Smaller Hospital Genetics Laboratory

  6. Evidence Based Review, Genomics-guided Immunotherapy for Cancer: TMB, Copy Number Burden, Neoepitopes, and Beyond

  7. Detection of Rearrangements by Next Generation Sequencing

  8. Challenges with Detection of Copy Number Aberrations and Copy-Neutral LOH by Next Generation Sequencing

  9. Developing an Observational Database of Somatic Copy Number Aberrations

  10. Integration of Molecular and Cytogenetics Didactic and Practical Training (ABMGG-LGG, in-service technologists)

  11. Practical Considerations for CMA Technology

  12. Best Practices and Clinical Utility of Circulating Tumor DNA Testing

  13. Constitutional Testing: The Roles for Optical Mapping, Mate Pair Sequencing, CMA, Cytogenetics and Other Sequencing)

  14. Developing Algorithms to Manage Test Selection and Resources

  15. Petitioning for Increased Reimbursement for Genomic Testing: Successes and Next Steps

  16. Best Practice and Clinical Utility of Genomic Testing for Diffuse Large B-cell Lymphoma

  17. Data Sharing of Multiple Myeloma Array and NGS Testing

  18. Best Practice and Clinical Utility of Genomic Testing for Pediatric Sarcomas

  19. New Director and Clinical Fellows Networking

  20. Discussing Experiences using Software for the Analysis and Reporting of Large-Scale Variants (CNV, LOH, Rearrangements) from CMA and/or NGS based methods